Allelic imbalance at chromosomal loci implicated in the pathogenesis of oral precancer, cumulative loss and its relationship with progression to cancer

Oral Oncology

Volumn 34, Issue 2, 1998, Pages 77-83

  Partridge, M ^a   Emilion, G ^a   Pateromichelakis, S ^b   A'Hern, R ^b   Phillips, E ^a   Langdon, J ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

Chromosome deletions; Genes; Loss of heterozygosity; Microsatellite markers; Mouth neoplasms; Oral cancer; Precancer; Suppressor; Tumour

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADULT; AGED; ARTICLE; CHROMOSOME 3P; CHROMOSOME 8P; CHROMOSOME 9P; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DYSPLASIA; ERYTHROPLASIA; FEMALE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MALE; MICROSATELLITE INSTABILITY; MOUTH CARCINOMA; PRECANCER; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0032033747     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(97)00052-3     Document Type: Article

References (24)

1. Largey JS, Meltzer SJ, Yin J, Norris K, Sauk JJ, Archibald DW. Loss of heterozygosity of p53 in oral cancers demonstrated by the polymerase chain reaction. Cancer 1993;71:1933-1937.
2. Lee NK, Ye Y-W, Li X, Schweitzer C, Nisen PD. Allelic loss on chromosome 13 can preceed histological changes in head and neck cancer. International Journal of Oncology 1994;5:205-210.
3. Maestro R, Piccinin S, Doglioni C, et al. Chromosome 13q deletion mapping in head and neck squamous cell carcinomas: iden-tification of two distinct regions of preferential loss. Cancer Research 1996;56:1146-1150.
4. Rowley H, Jones AS, Field J K. Chromosome 18: a possible site for a tumour suppressor gene deletion in squamous cell carcinoma of the head and neck. Clinical Otolaryngology 1995;20:266-271.
5. Cairns P, Polascik TJ, Eby Y, et al. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genetics 1995;11:210-212.
6. Partridge M, Kiguwa S, Langdon JD. Frequent deletion of chromosome 3p in oral squamous cell carcinoma. Oral Oncology European Journal of Cancer 1994;30B(4):248-251.
7. Wu CL, Sloan P, Read AP, Harris RH, Thakkar NS. Deletion mapping on the short arm of chromosome 3 in oral squamous cell carcinoma of the oral cavity. Cancer Research 1994;54:64846488.
8. Field JK, Tsiiriytos C, Zoumpourlis V. Allele loss on chromosome 3 in squamous cell carcinoma of the head and neck corelates with poor clinical prognostic indicators. International Journal of Oncology 1994;4:543-549.
9. Partridge M, Emilion G, Langdon JD. LOH at 3p correlates with a poor survival in oral squamous cell carcinoma. British Journal of Cancer 1996;73:366-371.
10. Kiaris H, Jones AS, Spandidos DA, Vaughan ED, Field JK. Loss of heterozygosity on chromosome 8 in squamous cell carcinomas of the head and neck. International Journal of Oncology 1994;5:1243-1248.
11. Van der Reit P, Nawroz H, Hruban RH, et al. Frequent loss of chromosome 9p21-22 in head and neck cancer progression. Cancer Research, 1994;54:1156-1158.
12. Ishwad CS, Ferrell RE, Rossie KM, et al. Loss of heterozygosity of the short arm of chromosomes 3 and 9 in oral cancer. International Journal of Cancer 1996;69:l-4.
13. Van Dyke DL, Worsham MJ, Benninger MS, et al. Recurrent cytogenetic abnormalities in squamous cell carcinomas of the head and neck region. Genes, Chromosomes and Cancer 1994;9:192-206.
14. Pindborg JJ, Daftary DK, Gupta P, et al. Public health aspects of oral cancer; implications for cancer prevention in the community In: Johnson NW, editor. Risk Markers for Oral Diseases, Vol. 2. Oral Cancer Detection of Patients and Lesions at Risk. Cambridge: Cambridge University Press, 1991. pp. 80-388.
15. Shafer W, Waldron C. Erythroplakia of the oral cavity. Cancer 1975;6:1021-1028.
16. MacDonald DG. Premalignant lesions of oral epithelium. In: Dolby AE, editor. Oral Mucosa in Health and Disease. Oxford: Blackwell Scientific Publications, pp. 345-369.
17. Ah-see KW, V Cooke TG, Pickford IR, Soutar D, Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Research 1994;54:1617-1621.
18. Field JK, Kiaris H, Risk JM, et al. Allelotype of squamous cell carcinoma of the head ad neck: fractional allele loss correlates with survival. British Journal of Cancer 1995;72:1180-1188.
19. Roz L, Wu CL, Porter C, et al. Allelic imbalance on chromosome 3p in oral dysplastic lesions: an early event in oral carcinogenesis. Cancer Research 1996;56:1228-1231.
20. Mao L, Lee JS, Fan YH, et al. Frequent microsatellite alterations at chromosome 9p and 3pl4 in oral premalignant lesions and their value in cancer risk assessment. Nature Medicines 1996;2:682-685.
21. Emilion G, Langdon JD, Speight P, Partridge M. Frequent gene deletions in potentially malignant oral lesions. British Journal of Cancer 1996;73:809-813.
22. Partridge M, Emilion G, Pateromichelakis S, Phillips E, Langdon J. Field cancerisation of the oral cavity: comparison of the spectrum of molecular alterations in cases presenting with both dysplastic and malignant lesions. Oral Oncology 1997, 332-337.
23. Califano J, van der Reit P, Westra W, et al. Genetic progression model for head and neck cancer: implications for field cancerisation. Cancer Research 1996;56:2488-2492.
24. El Naggar AK, Hurr K, Batsakis JG, Luna MA, Goepfert H, Huff V. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma. Cancer Research 1995;55:2656-2659.